ADORA2A and Alzheimer disease: Adenosine, deriving from an increase of ecto-5′-nucleotidase (CD73) activity in animal model of early AD, induced memory deficits, LTP impairment and synaptic markers reduction in a CD73 or A2A adenosine receptor-dependent way (Gonçalves et al., 2019).